Table 3.
Group | Mean baseline (±s.d.) | P | Mean week 2 (±s.d.) | Mean CBTW2 (±s.d.) | Mean week 4 (±s.d.) | Mean C2WAT (±s.d.) | |
---|---|---|---|---|---|---|---|
SF-36 | Control (n = 29) | 76.3 (5.5) | 0.95 | 85.8 (5.6) | 9.5 (6.1) | 79.9 (7) | 5.9 (3.7) |
Intervention (n = 31) | 76.8 (6) | 92.3 (4.8)∗ | 15.6 (6.8)∗ | 90.3 (5.2)∗ | 2 (2.9)∗ | ||
| |||||||
SF-36PH | Control (n = 29) | 74.5 (6.7) | 0.47 | 84.9 (6.2)∗ | 10.7 (6.4) | 78.8 (7.4) | 6 (4.1) |
Intervention (n = 31) | 75.7 (8) | 92.1 (5)∗ | 16.4 (8.9)∗ | 90.5 (6)∗ | 1.7 (2)∗ | ||
| |||||||
SF-36MH | Control (n = 29) | 76.2 (7) | 0.90 | 86.6 (5.9) | 11.1 (6.2) | 80.8 (6.8) | 4.7 (4.5) |
Intervention (n = 31) | 76.4 (6.9) | 92.4 (5.6)∗ | 16 (7.2)∗ | 91.4 (4.7)∗ | 1.9 (2.5)∗ |
P: P value; SF-36: 36-Item Short-Form Health Survey; SF-36PH: 36-Item Short-Form Health Survey physical health; SF-36MH: 36-Item Short-Form Health Survey mental health; mean CBTW2: mean change baseline to week 2; mean C2WAT: mean change 2 week after treatment; intervention: herbal medicine; control: hyoscine. ∗P < 0.001, intervention vs. control.